AU2007267801A1 - Administration of the REG1 anticoagulation system - Google Patents

Administration of the REG1 anticoagulation system Download PDF

Info

Publication number
AU2007267801A1
AU2007267801A1 AU2007267801A AU2007267801A AU2007267801A1 AU 2007267801 A1 AU2007267801 A1 AU 2007267801A1 AU 2007267801 A AU2007267801 A AU 2007267801A AU 2007267801 A AU2007267801 A AU 2007267801A AU 2007267801 A1 AU2007267801 A1 AU 2007267801A1
Authority
AU
Australia
Prior art keywords
aptamer
dose
antidote
aptt
anticoagulant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007267801A
Other languages
English (en)
Inventor
Christopher P. Rusconi
Ross M. Tonkens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Regado Biosciences Inc
Original Assignee
Regado Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regado Biosciences Inc filed Critical Regado Biosciences Inc
Publication of AU2007267801A1 publication Critical patent/AU2007267801A1/en
Priority to AU2013263868A priority Critical patent/AU2013263868A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
AU2007267801A 2006-05-26 2007-05-25 Administration of the REG1 anticoagulation system Abandoned AU2007267801A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2013263868A AU2013263868A1 (en) 2006-05-26 2013-12-02 Administration of the REG1 anticoagulation system

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US80898706P 2006-05-26 2006-05-26
US60/808,987 2006-05-26
US84780906P 2006-09-27 2006-09-27
US60/847,809 2006-09-27
US86535206P 2006-11-10 2006-11-10
US60/865,352 2006-11-10
PCT/US2007/012625 WO2007140000A2 (en) 2006-05-26 2007-05-25 Administration of the reg1 anticoagulation system

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2013263868A Division AU2013263868A1 (en) 2006-05-26 2013-12-02 Administration of the REG1 anticoagulation system

Publications (1)

Publication Number Publication Date
AU2007267801A1 true AU2007267801A1 (en) 2007-12-06

Family

ID=38779273

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007267801A Abandoned AU2007267801A1 (en) 2006-05-26 2007-05-25 Administration of the REG1 anticoagulation system

Country Status (11)

Country Link
US (1) US20090048193A1 (ru)
EP (1) EP2026653A4 (ru)
JP (2) JP2009538325A (ru)
KR (1) KR20090015118A (ru)
CN (1) CN101453891B (ru)
AU (1) AU2007267801A1 (ru)
CA (1) CA2653313A1 (ru)
IL (1) IL194991A0 (ru)
RU (1) RU2568579C2 (ru)
WO (1) WO2007140000A2 (ru)
ZA (1) ZA200809575B (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2682580A1 (en) 2007-03-30 2008-10-09 Duke University A method of modulating the activity of a nucleic acid molecule
US8889646B2 (en) 2009-06-03 2014-11-18 Regado Biosciences, Inc. Nucleic acid modulators of glycoprotein VI
US8889645B2 (en) 2009-06-03 2014-11-18 Regado Biosciences, Inc. Nucleic acid modulators of glycoprotein VI
AU2010256511B2 (en) * 2009-06-03 2016-01-14 Tobira Therapeutics, Inc. Nucleic acid modulators of glycoprotein VI
AR077405A1 (es) 2009-07-10 2011-08-24 Sanofi Aventis Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer
FR2949467B1 (fr) 2009-09-03 2011-11-25 Sanofi Aventis Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
US9468650B2 (en) 2009-09-16 2016-10-18 Duke University Inhibition of endosomal toll-like receptor activation
KR20180128097A (ko) * 2012-02-10 2018-11-30 재패닉 코포레이션 비 인간 줄기세포의 배양 상등액을 원료로 하는 화장품 또는 피부 재생 촉진제, 및 단백질의 이온 도입 방법
KR20220139425A (ko) 2012-07-13 2022-10-14 웨이브 라이프 사이언시스 리미티드 키랄 제어
FR3011250A1 (fr) * 2013-09-30 2015-04-03 Lab Francais Du Fractionnement Acides nucleiques se liant specifiquement au facteur ix/ixa humain, et utilisations
US10066323B2 (en) 2014-04-16 2018-09-04 Duke University Electrospun cationic nanofibers and methods of making and using the same
US10660973B2 (en) 2015-04-28 2020-05-26 Duke University Thrombus imaging aptamers and methods of using same
JP2019528739A (ja) 2016-09-16 2019-10-17 デューク ユニバーシティ フォン・ビルブラント因子（ｖｗｆ）標的薬剤およびそれを用いる方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19935303A1 (de) * 1999-07-28 2001-02-08 Aventis Pharma Gmbh Oligonukleotide zur Inhibierung der Expression von humanem eg5
US7300922B2 (en) * 2001-05-25 2007-11-27 Duke University Modulators of pharmacological agents
KR101185050B1 (ko) * 2004-04-22 2012-10-04 레가도 바이오사이언스, 인코포레이티드 응고 인자의 개선된 모듈레이터

Also Published As

Publication number Publication date
US20090048193A1 (en) 2009-02-19
CA2653313A1 (en) 2007-12-06
WO2007140000A3 (en) 2008-02-28
ZA200809575B (en) 2015-04-29
EP2026653A2 (en) 2009-02-25
WO2007140000A2 (en) 2007-12-06
IL194991A0 (en) 2009-08-03
RU2568579C2 (ru) 2015-11-20
KR20090015118A (ko) 2009-02-11
RU2012136951A (ru) 2014-03-10
CN101453891B (zh) 2013-12-11
CN101453891A (zh) 2009-06-10
JP2009538325A (ja) 2009-11-05
EP2026653A4 (en) 2011-11-16
JP2014148515A (ja) 2014-08-21

Similar Documents

Publication Publication Date Title
US20090048193A1 (en) Administration of the REG1 anticoagulation system
US8859518B2 (en) Modulators of coagulation factors
EP1401853B1 (en) Modulators of pharmacological agents
AU2010256511B2 (en) Nucleic acid modulators of glycoprotein VI
US20090163437A1 (en) Steady-state subcutaneous administration of aptamers
AU2013263868A1 (en) Administration of the REG1 anticoagulation system
RU2464030C2 (ru) Введение противосвертывающей системы reg1
US8889646B2 (en) Nucleic acid modulators of glycoprotein VI
UA94948C2 (en) Administration of the reg1 anticoagulation system
AU2012244176B8 (en) Modulators of pharmacological agents

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted